186 related articles for article (PubMed ID: 21656555)
1. Longitudinal inter- and intra-individual human brain metabolic quantification over 3 years with proton MR spectroscopy at 3 T.
Kirov II; George IC; Jayawickrama N; Babb JS; Perry NN; Gonen O
Magn Reson Med; 2012 Jan; 67(1):27-33. PubMed ID: 21656555
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional and longitudinal reproducibility of rhesus macaque brain metabolites: a proton MR spectroscopy study at 3 T.
Wu WE; Kirov II; Zhang K; Babb JS; Joo CG; Ratai EM; González RG; Gonen O
Magn Reson Med; 2011 Jun; 65(6):1522-31. PubMed ID: 21337426
[TBL] [Abstract][Full Text] [Related]
3. Diurnal stability and long-term repeatability of neurometabolites using single voxel 1H magnetic resonance spectroscopy.
Al-Iedani O; Arm J; Ribbons K; Lea R; Lechner-Scott J; Ramadan S
Eur J Radiol; 2018 Nov; 108():107-113. PubMed ID: 30396641
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of 1H-MRS in vivo.
Brooks WM; Friedman SD; Stidley CA
Magn Reson Med; 1999 Jan; 41(1):193-7. PubMed ID: 10025629
[TBL] [Abstract][Full Text] [Related]
5. Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T.
Davitz MS; Wu WE; Soher BJ; Babb JS; Kirov II; Huang J; Fatterpekar G; Gonen O
Magn Reson Imaging; 2017 Jan; 35():15-19. PubMed ID: 27580518
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes during aging using proton magnetic resonance spectroscopy.
Ross AJ; Sachdev PS; Wen W; Brodaty H
J Gerontol A Biol Sci Med Sci; 2006 Mar; 61(3):291-8. PubMed ID: 16567380
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging.
Chard DT; McLean MA; Parker GJ; MacManus DG; Miller DH
J Magn Reson Imaging; 2002 Feb; 15(2):219-25. PubMed ID: 11836781
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility and reliability of short-TE whole-brain MR spectroscopic imaging of human brain at 3T.
Ding XQ; Maudsley AA; Sabati M; Sheriff S; Dellani PR; Lanfermann H
Magn Reson Med; 2015 Mar; 73(3):921-8. PubMed ID: 24677384
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
Baruth JM; Wall CA; Patterson MC; Port JD
Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
[TBL] [Abstract][Full Text] [Related]
11. Diurnal variability of cerebral metabolites in healthy human brain with 2D localized correlation spectroscopy (2D L-COSY).
Arm J; Al-Iedani O; Lea R; Lechner-Scott J; Ramadan S
J Magn Reson Imaging; 2019 Aug; 50(2):592-601. PubMed ID: 30629765
[TBL] [Abstract][Full Text] [Related]
12. Brain metabolites B1-corrected proton T1 mapping in the rhesus macaque at 3 T.
Liu S; Fleysher R; Fleysher L; Joo CG; Ratai EM; González RG; Gonen O
Magn Reson Med; 2010 Apr; 63(4):865-71. PubMed ID: 20373387
[TBL] [Abstract][Full Text] [Related]
13. Non-water-suppressed proton MR spectroscopy improves spectral quality in the human spinal cord.
Hock A; MacMillan EL; Fuchs A; Kreis R; Boesiger P; Kollias SS; Henning A
Magn Reson Med; 2013 May; 69(5):1253-60. PubMed ID: 22745036
[TBL] [Abstract][Full Text] [Related]
14. MRS of normal and impaired fetal brain development.
Girard N; Fogliarini C; Viola A; Confort-Gouny S; Fur YL; Viout P; Chapon F; Levrier O; Cozzone P
Eur J Radiol; 2006 Feb; 57(2):217-25. PubMed ID: 16387464
[TBL] [Abstract][Full Text] [Related]
15. Metabolite proton T(2) mapping in the healthy rhesus macaque brain at 3 T.
Liu S; Gonen O; Fleysher R; Fleysher L; Babb JS; Soher BJ; Joo CG; Ratai EM; González RG
Magn Reson Med; 2009 Nov; 62(5):1292-9. PubMed ID: 19780178
[TBL] [Abstract][Full Text] [Related]
16. Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability.
Wiedermann D; Schuff N; Matson GB; Soher BJ; Du AT; Maudsley AA; Weiner MW
Magn Reson Imaging; 2001 Oct; 19(8):1073-80. PubMed ID: 11711231
[TBL] [Abstract][Full Text] [Related]
17. Potential of MR spectroscopy for assessment of glioma grading.
Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.
Catani M; Mecocci P; Tarducci R; Howard R; Pelliccioli GP; Mariani E; Metastasio A; Benedetti C; Senin U; Cherubini A
J Am Geriatr Soc; 2002 Oct; 50(10):1707-10. PubMed ID: 12366626
[TBL] [Abstract][Full Text] [Related]
19. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
Lyoo IK; Kong SW; Sung SM; Hirashima F; Parow A; Hennen J; Cohen BM; Renshaw PF
Psychiatry Res; 2003 Jun; 123(2):87-100. PubMed ID: 12850248
[TBL] [Abstract][Full Text] [Related]
20. APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain.
Gomar JJ; Gordon ML; Dickinson D; Kingsley PB; Uluğ AM; Keehlisen L; Huet S; Buthorn JJ; Koppel J; Christen E; Conejero-Goldberg C; Davies P; Goldberg TE
Biol Psychiatry; 2014 May; 75(9):686-92. PubMed ID: 23831342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
